Ozempic, Wegovy linked to severe medical conditions ... - NBC News
WEBPeople who take popular drugs for weight loss, such as Ozempic or Wegovy, may be at an increased risk of severe stomach problems, research published Thursday in the Journal of the American...
Ozempic may be linked to condition that causes blindness ... - NBC News
WEBJul 3, 2024 · People taking Ozempic and Wegovy may be at increased risk of developing a debilitating eye condition that can cause irreversible vision loss, a study published Wednesday in JAMA Ophthalmology...
Ozempic reduces risk of serious illness and death in people with ... - CNN
WEBMay 24, 2024 · Weekly injections of semaglutide medications like Ozempic significantly reduce the risk of serious kidney outcomes, major cardiovascular events and death among people who have type 2 diabetes and...
What it’s like to stay on Ozempic for years - NBC News
WEBAfter about two years of taking Ozempic for diabetes or weight loss, people say they still have to stay diligent about diet and exercise.
How Ozempic Is Changing Diabetes Treatment - The New York Times
WEBMay 13, 2024 · How Ozempic Is Changing Diabetes Treatment - The New York Times. Millions of patients rely on insulin. But with new drugs, some have been able to lower their doses or stop taking it altogether....
New study ties weight-loss drugs Wegovy, Ozempic to serious ...
WEBOct 5, 2023 · A study suggests that weight-loss drugs Wegovy and Ozempic, which belong to the GLP-1 inhibitor class, may increase the risk of pancreatitis, intestinal blockage and stomach paralysis. Health...
Ozempic May Help Treat Kidney Disease, Study Finds - The New York Times
WEBMay 24, 2024 · Semaglutide, the compound in the blockbuster drugs Ozempic and Wegovy, dramatically reduced the risk of kidney complications, heart issues and death in people with Type 2 diabetes and chronic...
What Is Ozempic and Why Is It Getting So Much Attention?
WEBNov 22, 2022 · Ozempic, a drug used to treat diabetes, keeps gaining attention as celebrities, a tech mogul and TikTok influencers have described taking it to lose weight in short time frames.
As Semaglutide’s Popularity Soars, Rare but Serious Adverse …
WEBSemaglutide, a GLP-1 agonist for weight loss and diabetes, can cause pancreatitis, bowel obstruction, and gastroparesis, according to a JAMA study. The article also discusses the risks of vomiting and aspiration during anesthesia with semaglutide.
Ozempic predecessor suggests potential for GLP-1 drugs in ... - CNN
WEBA small clinical trial suggests that drugs like Ozempic could potentially be used not just for diabetes and weight loss but to protect the brain, slowing the rate at which people with …